Related Funds
Fund Name | Location |
AKQA | England, London, United Kingdom |
ALiNK Internet | Japan, Tokyo |
ATP | - |
Beijing Opera and Dance Theater | Beijing, Beijing, China |
Cardworks | New York, United States, Woodbury |
Critical Path Inc. | California, San Mateo, United States |
EMVC | District of Columbia, United States, Washington |
Founders Forum | England, London, United Kingdom |
Grayhawk Capital | Arizona, Phoenix, United States |
Huiruying Investment | China, Guangdong Province, Huizhou |
Joint Capital | China, Ningbo, Zhejiang |
Merz Venture Initiative | - |
Newbury Ventures | California, Menlo Park, United States |
Ransomshire Associates, Inc. | North Carolina, Rolesville, United States |
Relevant Health | Maryland, Rockville, United States |
Renoveru | Chiyoda, Japan |
Samsung Strategy and Innovation Center | California, Menlo Park, United States |
Shanghai Zhongfu Equity Investment Management | China, Shanghai |
SKIYAKI Corp. | Chiyoda, Japan |
Sun Capital Partners | Boca Raton, Florida, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Hongchen Biotech | 21 Oct 2024 | - | |||
Mavel Technology | 10 Aug 2023 | Beijing, Beijing, China | |||
Juventas | $63M | 12 Jul 2021 | Chaoyang City, Liaoning, China | ||
Fantai Data | $2M | 17 Jan 2019 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Hongchen Biotech | 21 Oct 2024 | - | |||
Mavel Technology | 10 Aug 2023 | Beijing, Beijing, China | |||
Juventas | $63M | 12 Jul 2021 | Chaoyang City, Liaoning, China | ||
Fantai Data | $2M | 17 Jan 2019 | Shanghai, China |